Current Drug Discovery Technologies

ISSN: 1570-1638 - Volume 5, 4 Issues, 2008



Editorial Advisory Board:

B.B. Aggarwal (University of Texas MD Anderson Cancer Center, Texas, USA)
C. Ahlberg (Spotfire, Massachusetts, USA)
T.A. Andreevich (Institute of Geology & Geophysics of Academy Science, Tashkent, Republic Uzbekistan)
G.D. Armstrong (University of Calgary, Calgary, Alberta, Canada)
A.M. Aronov (Vertex Pharmaceuticals, Inc., Cambridge, MA, USA)
Y. Audigier (Institute of Molecular Medecine of Rangueil, U858 INSERM, France)
D.L. Banville (AstraZeneca Pharmaceuticals, Wilmington, DE, USA)
J. Bayry (Centre de Recherche des Cordeliers, Paris, France)
G. Bazylak (Nicolaus Copernicus University, Bydgoszcz, Poland)
S.J. Benkovic (The Pennsylvania State University, Pennsylvania, USA)

D. Boison (R.S. Dow Neurobiology Laboratories, Portland, OR, USA)
M. Braddock (AstraZeneca R&D Charnwood, Leictershire, UK)
C.R. Bramham (University of Bergen, Bergen, Norway)
S. Brase (University of Karlsruhe, Karlsruhe, Germany)
R. Breslow (Columbia University, New York, USA)
M.H. Bronchud (Hospital General of Granollers, Barcelona, Spain)
M.B. Brown (University of Hertfordshire, Herts, UK)
R. Bucala (Yale University School of Medicine, New Haven, CT, USA)
E.A. Castro (Universidad Nacional de La Plata, La Plata, Argentina)
G.L. Challis (University of Warwick, Coventry, UK)
K.K. Chan (The Ohio State University, Ohio, OH, USA)
J.P.F. Chin-Dusting (Baker Heart Research Institute, Melbourne, Australia)
P. Colas (Station Biologique, Place Georges Teissier, Roscoff, France)
R.A. Copeland (GlaxoSmithKline, Collegeville, PA, USA)
R. Cortesi (Ferrara University, Ferrara, Italy)
M. Crawford (Cerep, Inc., Washington, USA)
M. Cristofanilli (The University of Texas, Houston, TX, USA)
J.-V. De Julian Ortiz (Polytechnic University of Valencia, Valencia, Spain)
M.M. De Villiers (University of Wisconsin, Madison, WI, USA)
U.M.G. Döbbeling (University Hospital Zurich, Zurich, Switzerland)
J. Drews (Bear Stearns Health Innoventure, New York, NY, USA)
T.L. Dunckley (Translational Genomics Research Institute, Phoenix, AZ, USA)
E. Estrada (University of Santiago de Compostela, Santiago de Compostela, Spain)
Y. Fang (Corning Inc., Corning, NY, USA)
M. Feher (The Campbell Family Institute for Breast Cancer Research, Toronto, ON, Canada)
W.Y. Feng (Bridge Pharmaceuticals, Beijing, China)
D.R. Flower (University of Oxford, Berkshire, UK)
A. Fura (Bristol-Myers Squibb R&D, Princeton, NJ, USA)
Z.-G. Gao (National Institutes of Health, Bethesda, MD, USA)
G. Gardiner (Yale University, Connecticut, USA)
L. Ghosez (European Institute of Chemistry and Biology, France)
J.C. Glorioso (University of Pittsburgh, Pittsburgh, PA, USA)
B. Gold (National Cancer Institute, Frederick, MD, USA)
J.A. Grosso (Bristol-Myers Squibb R&D, Princeton, NJ, USA)
C.P. Hart (Threshold Pharmaceuticals, Redwood City, CA, USA)
A. Hillisch (Bayer HealthCare AG, Wuppertal, Germany)
K. Houk (University of California, California, USA)
J. Huard (University of Pittsburgh, Pittsburgh, PA, USA)
D.W. Hutmacher (National University of Singapore, Singapore, Singapore)
M. Ishido (National Institute for Environmental Studies, Tsukuba, Japan)
K. Islam (Arpida, Switzerland)
J.W. Janetka (AstraZeneca R&D Boston, Waltham, MA, USA)
Z.L. Ji (Xiamen University, Fujian, China)
J. Kardos (Hungarian Academy of Sciences, Budapest, Hungary)
K. Kariko (University of Pennsylvania School of Medicine, Philadelphia, PA, USA)
S. Klussmann (Noxxon Pharma AG, Berlin, Germany)
A. Kolb (KeyTech Solutions, Connecticut, USA)
T.A. Kost (GlaxoSmithKline, Research Triangle Park, NC, USA)
W.A. Korfmacher (Schering-Plough Research Institute, Kenilworth, NJ, USA)
M. Komada (Tokyo Institute of Technology, Yokohama, Japan)
M.S. Lajiness (Eli Lilly and Company, Corporate Circle, Indianapolis, IN, USA)
J.M. Lehn (Nobel Laureate) Institut Le Bel, France)
J.-P. Leonetti (Centre de Pharmacologie et Biotechnologie pour la Sante, Montpeillier, France)
C. Lipinski (Pfizer Global R&D, Connecticut, USA)
S.A. Lipton (Burnham Institute for Medical Research, La Jolla, CA, USA)
S. Liu (Schering-Plough Research Institute, Kenilworth, NJ, USA)
E. Lolis (Yale University, New Haven, CT, USA)
K. Maggon (Pharma Biotech R&D, Geneva,Switzerland)
M. Maqueda (University of Granada, Granada, Spain)
C.R. Martin (University of Florida, Gainesville, FL, USA)
N. Maulik (University of Connecticut School of Medicine, Farmington, CT, USA)
T.A. McKinsey (University of Colorado, Denver, CO, USA)
L.K. Minor (Johnson & Johnson Pharmaceutical R&D, Spring House, PA, USA)
L. Mitscher (University of Kansas, Kansas, USA)
S.M. Moghimi (University of Brighton, Brighton, UK)
M. Moloney (University of Oxford, Oxford, UK)
R. Morphy (Organon Laboratories Ltd., Motherwell, UK)
K. Mueller (Hoffman-La Roche Ltd, Switzerland)
D.J. Muller (University of Technology Dresden, Dresden, Germany)
M. Murcko (Vertex Pharm,Cambridge, MA, USA)
J.P. O'Bryan (University of Illinois College of Medicine, Chicago, IL, USA)
T. Ochiya (National Cancer Center Research Institute, Tokyo, Japan)
H. Onishi (Hoshi University, Tokyo, Japan)
E. Paleolog (Imperial College, London, UK)
K.H. Pearce (GlaxoSmithKline, Research Triangle Park, NC, USA)
R.T. Peterson (Massachusetts General Hospital, Charlestown, MA, USA)
Y.G. Pommier (National Institutes of Health, Bethesda, MD, USA)
I.N. Rich (HemoGenix, Inc., Colorado Springs, CO, USA)
D.D. Root (University of North Texas, Denton, TX, USA)
A.P. Russ (University of Oxford, Oxford, UK)
M. Ruvo (University of Naples, Napoli, Italy)
D.K. Sarker (University of Brighton, Brighton, UK)
J. Schlessinger (Yale University, Connecticut, USA)
K.B. Sharpless (The Scripps Research Institute (TSRI), California, USA)
P.J. Sinko (Rutgers University, Piscataway, NJ, USA)
M. Simonyi (Institute of Chemistry, Chemical Research Center, Budapest, Hungary)
C.P. Sosa (University of Minnesota, Minneapolis, MN, USA)
M. Spedding (Institute of Research Servier, Suresnes, France)
L. Stewart (deCODE biostructures Inc., Bainbridge Island, WA, USA)
G. Subramanian (Sanofi-aventis, New Jersey, NJ, USA)
K. Sugahara (Hokkaido University Graduate School of Life Science, Hokkaido, Japan)
D.R. Taft (Long Island University, Brooklyn, NY, USA)
P. Talaga (UCB Chemin du Foriest, Braine-l'Alleud, Belgium)
I.V. Tetko (Institute for Bioinformatics, Neuherberg, Germany)
V.P. Torchilin (Northeastern University, Boston, MA, USA)
F. Torrens (University of Valencia, Valencia, Spain)
G. Trainor (Bristol-Myers Squibb Pharmaceutical, Delaware, USA)
S.M. Turner (KineMed, Inc., Emeryville, CA, USA)
J. Vaidyanathan (University of Medicine and Dentistry of NJ, Newark, NJ, USA)
M.A. Velleca (CGI Pharmaceuticals, Inc., Branford, CT, USA)
F. Vinick (Genzyme, Massachusetts, USA)
M.A. Walker (Bristol-Myers Squibb R&D, Wallingford, CT, USA)
J.J. Wang (Wyeth Pharmaceuticals, Pennsylvania, USA)
P.A. Wender (Stanford University, California, USA)
L.C. Wienkers (Amgen Inc., Seattle, WA, USA)
M.S. Wolfe (Harvard Medical School, Boston, MA, USA)
S. Yamagishi (Kurume University School of Medicine, Kurume, Japan)
A.K. Yudin (University of Toronto, Toronto, Ontario, Canada)
Y. Zhang (Johns Hopkins University, Baltimore, MD, USA)
X.F.S. Zheng (UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ, USA)
J. Zhou (Acenta Discovery, Inc., Tucson, AZ, USA)

Copyright © Bentham Science Publishers Ltd    Terms and Conditions
toptop